As processes and equipment in the pharmaceutical industry undergo extensive validation and qualification programs, every event representing a deviation from validated processes, approved procedures or regulations requires a thorough and in-depth investigation to assess its potential impact on the product's safety, quality and compliance.
The deviation management process is a requirement and is designed to be a part of the Quality Management System (QMS) imposed by all major GMP regulators, including EMA and the FDA.